Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pep
The acquisition of multi-kilogram GMP and fill-finish capabilities enables the support of all phases of the product life cycle from discovery to commercialisation.STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pe...
Source: pharmiweb.com
